Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 4
1997 2
1998 3
1999 5
2000 3
2001 3
2002 2
2003 7
2004 3
2005 4
2006 5
2007 6
2008 9
2009 9
2010 6
2011 4
2012 6
2013 6
2014 2
2015 8
2016 2
2017 4
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Hepatitis C virus vaccines--progress and perspectives.
Fauvelle C, Lepiller Q, Felmlee DJ, Fofana I, Habersetzer F, Stoll-Keller F, Baumert TF, Fafi-Kremer S. Fauvelle C, et al. Among authors: stoll keller f. Microb Pathog. 2013 May;58:66-72. doi: 10.1016/j.micpath.2013.02.005. Epub 2013 Mar 7. Microb Pathog. 2013. PMID: 23499591 Review.
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
Fafi-Kremer S, Fauvelle C, Felmlee DJ, Zeisel MB, Lepiller Q, Fofana I, Heydmann L, Stoll-Keller F, Baumert TF. Fafi-Kremer S, et al. Among authors: stoll keller f. Viruses. 2012 Oct 9;4(10):2016-30. doi: 10.3390/v4102016. Viruses. 2012. PMID: 23202451 Free PMC article. Review.
Challenges for HCV vaccine development in HIV-HCV coinfection.
Lambotin M, Barth H, Moog C, Habersetzer F, Baumert TF, Stoll-Keller F, Fafi-Kremer S. Lambotin M, et al. Among authors: stoll keller f. Expert Rev Vaccines. 2012 Jul;11(7):791-804. doi: 10.1586/erv.12.52. Expert Rev Vaccines. 2012. PMID: 22913257 Review.
Neutralizing antibodies in hepatitis C virus infection.
Zeisel MB, Fafi-Kremer S, Fofana I, Barth H, Stoll-Keller F, Doffoel M, Baumert TF. Zeisel MB, et al. Among authors: stoll keller f. World J Gastroenterol. 2007 Sep 28;13(36):4824-30. doi: 10.3748/wjg.v13.i36.4824. World J Gastroenterol. 2007. PMID: 17828813 Free PMC article. Review.
Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.
Solis M, Velay A, Porcher R, Domingo-Calap P, Soulier E, Joly M, Meddeb M, Kack-Kack W, Moulin B, Bahram S, Stoll-Keller F, Barth H, Caillard S, Fafi-Kremer S. Solis M, et al. Among authors: stoll keller f. J Am Soc Nephrol. 2018 Jan;29(1):326-334. doi: 10.1681/ASN.2017050532. Epub 2017 Oct 17. J Am Soc Nephrol. 2018. PMID: 29042457 Free PMC article.
Cytomégalovirus humain et cancers.
Lepiller Q, Fafi-Kremer S, Stoll-Keller F, Herbein G. Lepiller Q, et al. Among authors: stoll keller f. Virologie (Montrouge). 2012 Oct 1;16(5):315-329. doi: 10.1684/vir.2012.0462. Virologie (Montrouge). 2012. PMID: 33065915 English.
97 results